Eliem Therapeutics, Inc.

NasdaqGM:ELYM Stock Report

Mkt Cap: US$89.5m

Eliem Therapeutics Management

How experienced are the management team and are they aligned to shareholders interests?


Average management tenure


Bob Azelby (54 yo)

no data




Mr. Robert W. Azelby, also known as Bob, M.B.A., serves as the President and Director at Eliem Therapeutics, Inc. and serves as its Chief Executive Officer since October 2020. He has been an Independent Di...

CEO Compensation Analysis

How has Bob Azelby's remuneration changed compared to Eliem Therapeutics's earnings?
DateTotal Comp.SalaryCompany Earnings
Sep 30 2022n/an/a


Jun 30 2022n/an/a


Mar 31 2022n/an/a


Dec 31 2021US$7mUS$600k


Sep 30 2021n/an/a


Jun 30 2021n/an/a


Mar 31 2021n/an/a


Dec 31 2020US$678kUS$150k


Compensation vs Market: Bob's total compensation ($USD7.15M) is above average for companies of similar size in the US market ($USD726.26K).

Compensation vs Earnings: Bob's compensation has increased whilst the company is unprofitable.

Leadership Team

Robert Azelby
President2.33yrsUS$7.15mno data
Erin Lavelle
Executive VP2.33yrsUS$2.55m0%
$ 0
Valerie Morisset
Chief Scientific Officer and Executive VP of Research & Development3.83yrsUS$2.53m0.57%
$ 506.6k
James Bucher
Executive VP2.33yrsno datano data
Jo Palmer-Phillips
Chief Development Officerno datano datano data
Mark Versavel
Senior VP & Chief Medical Officer1.08yrsno datano data
Susan Franks
Senior VP & Head of Regulatory Affairs0.83yrno datano data


Average Tenure


Average Age

Experienced Management: ELYM's management team is considered experienced (2.3 years average tenure).

Board Members

Robert Azelby
Presidentno dataUS$7.15mno data
Adam Rosenberg
Independent Director2.33yrsUS$183.95k0.67%
$ 600.2k
Simon Tate
Independent Director4yrsUS$165.57k0%
$ 0
Andrew Levin
Independent Chairman4yrsUS$193.82k0%
$ 0
Judith Dunn
Independent Director2yrsUS$329.07k0%
$ 0
Liam Ratcliffe
Independent Director3.33yrsUS$182.99k0%
$ 0


Average Tenure


Average Age

Experienced Board: ELYM's board of directors are considered experienced (3.3 years average tenure).